Press release
Infectious Disease Therapeutics Market is expected to reach USD 154.18 Billion by 2023 | Key players are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Achillion Pharmaceuticals, Novartis.
Infectious Disease Therapeutics Market was valued at USD 105.13 Billion in 2018 and projected to reach USD 154.18 Billion by 2023 growing at a CAGR of 7.96% during the forecast period 2018 to 2023.
Infectious Disease Therapeutics Market Overview:
Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites. These diseases can be transmitted to each other by direct or indirect contact. Anti-infective medications are used to inhibit the growth of the disease. These medications can work through the host defense system and can be directed to the responsible agent. Worldwide, infectious diseases such as malaria, HIV, tuberculosis, influenza, hepatitis A and hepatitis C pose serious public health problems. These diseases are, therefore, the leading cause of death in the world.
Browse details of 94 number of pages research report developed on
Infectious Disease Therapeutics Market @ https://www.researchcosmos.com/reports/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
Infectious Disease Therapeutics Market Growth Drivers and Restraints:
The main factors driving market growth are the proliferation of infectious diseases, the increasing use of direct-acting antivirals, the rise in health care expenditures, the growth in the geriatric population, the increase in health awareness and augmenting public funds in developing countries. The main factor that hinders the growth of the market is the generic erosion, and the expiration of the patents of medicines against infectious diseases.
Geographic Insights of Infectious Disease Therapeutics Market:
North America is expected to represent the largest proportion of the market, followed by the Asia-Pacific region and Europe due to the increasing incidence of infectious diseases and the aging of the population. The Asia-Pacific region is expected to register the highest compound annual growth rate during the review period due to increased government funding in its emerging countries such as India and China.
Despite the increase in control measures, many infectious diseases are emerging, reappearing or causing recurrent outbreaks, particularly in the Asia-Pacific region. The most developed countries in the Asia-Pacific region, such as Japan and Australia, have a strong history of fighting infectious diseases, although the prevalence of infectious diseases in this region is high.
The health service delivery system in the Asia-Pacific region, the majority financed by private funds, is the most prone to economic recessions, although it is partially offset by the fact that much of traditional medicine. China is the largest market for the infectious disease therapies market in Asia-Pacific, accounting for 27% of the market in 2016.
Ask Free Sample of the report @ https://www.researchcosmos.com/request/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
Key Market Players of Infectious Disease Therapeutics Market:
Some of the major companies operating in global Infectious disease Therapeutics Market are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, and Sanofi.
Infectious Disease Therapeutics Market Key Segmentation:
By Type:
• HIV infection
• Influenza
• Malaria
• Tuberculosis
• Hepatitis
• HPV infection
By Application:
• Hospital
• Clinic
• Research Institute
• Laboratories
By Region:
• North America
• South America
• Europe
• Asia Pacific
• Middle East and Africa
For any queries, inquire more @ https://www.researchcosmos.com/inquire/global-infectious-disease-therapeutics-market-size-status-and-forecast-2025/2964923
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Therapeutics Market is expected to reach USD 154.18 Billion by 2023 | Key players are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Achillion Pharmaceuticals, Novartis. here
News-ID: 1655763 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Infectious
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63
The U.S. FDA (United States Food and Drug Administration) is…
Infectious Disease Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Infectious Disease Therapeutics Market is expected to grow from USD 48.77 billion in 2021 to USD 57.21 billion in 2026, at a CAGR of 7.12%. Rising infectious disease, increasing number of surgeries, high prevalence of chronic diseases such as cardiovascular and cancer, rising cases of accidents, changing food habits, lack of proper sanitation measures taken by healthcare providers are some of…
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which…
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of…
Announcement of Conference: Infectious Disease 2019 | Singapore
With immense pleasure and gratitude, We welcome all the professionals to attend the “International Conference on Pathology and Infectious Diseases” scheduled during November 11-12, 2019 at Singapore.
Infectious Disease 2019 aims to gather the Researchers, Scientists, Professors, Business Delegates experts, Research Scholars and Students working under life science and health care commerce. Infectious Disease conference delivers an international forum for the broadcasting of original research results, new concepts and real-world experiences…
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques.
The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased…
